Advertisement ZoomMed and Boeringer Ingelheim sign renewal agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ZoomMed and Boeringer Ingelheim sign renewal agreement

ZoomMed has announced that Boehringer Ingelheim has signed a renewal agreement, for the diffusion of information to physicians using the ZRx Prescriber.

The ‘ZRx Prescriber’ is a Web application that runs on a pocket computer or a personal computer. The tool is used by physicians to fill out prescriptions and make them available to pharmacists, who can view them online via unique barcodes and confirm them using the physician’s signed copy.

Yves Marmet, CEO of ZoomMed, said: “This renewal agreement with Boehringer Ingelheim, for a second consecutive year, proves that the ZRx Prescriber is a valuable and durable market solution, both from the technology and the market acceptance points of view.

The ZRx Prescriber represents a direct way of accessing physicians in an effort to properly represent products, ability to post educational messages, compliance programs, etc.”